Syndax Pharmaceuticals Inc. (SNDX)
Market Closed
10 Sep, 20:00
$
18. 82
-1.02
-5.1411%
Pre Market
$
+0.31 +1.6472% 19. 13
1.82B Market Cap
- P/E Ratio
- Div Yield
1.65M Volume
-2.96 Eps
$ 19.84
Previous Close 
Want to track SNDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Syndax Pharmaceuticals Inc. (SNDX) Statistics
Valuation metrics
Market Cap 1.82B
Enterprise value 2.07B
Trailing P/E (ttm) -8.16
Forward P/E -90.26
PEG ratio -0.17
Price/Sales (ttm) 7.23
Price/Book (mrq) 121.18
Enterprise Value/Revenue 8.23
Enterprise Value/EBITDA -15.34
Overview
Shares outstanding 88.54M
Float 75.1M
Shares short 19.91M
% Held by insiders 0.02%
% Held by institutions 1.16%
Average volume (10 days) 1.36M
Average volume (90 days) 1.53M
Price summary
52-Week low 12.99
52-Week high 25.59
Beta 0.41
50-Day moving average 19.96
200-Day moving average 21.62
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.88%
Operating margin -0.77%
Operational effectiveness
Return on assets -0.31%
Return on equity -3.73%
Income Statement
Revenue (ttm) 217.17M
Revenue per share (ttm) 2.83
Quarterly revenue growth (yoy) 2.24%
Gross profit (ttm) -50.33M
EBITDA -224.17M
Net income to common (ttm) -243.25M
Diluted EPS (ttm) -2.48
Quarterly earnings growth (yoy) 2.24%
Balance Sheet
Total cash (mrq) 361.24M
Total cash per share (mrq) 6.16
Total debt (mrq) 345.36M
Total Debt/Equity (mrq) 39.03
Current ratio (mrq) 6.77%
Book value per share (mrq) 0.17
Cash Flow
Cash flow statement -278.16M
Levered free cash flow (LFCF) -186.26M
